2026 · 1st Quarter (Jan 1 - Mar 31)

ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.")

Filed by WILLIAMS AND JENSEN, PLLC.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 20, 2026
Income: $80,000.00
Expenses: Not reported
Registrant: WILLIAMS AND JENSEN, PLLC
Client: ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.")
Filing UUID: 007882e6-db64-4d6c-af43-3f794c3e947d
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., the "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4307) and the "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, the "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels. Issues related to continuous glucose monitors.

Literal federal measure citations: S. 4307, H.R. 2005, S. 2951, H.R. 2902, S. 1406

BUD · Budget/Appropriations

FY 2027 Appropriations.

TAX · Taxation/Internal Revenue Code

Specific issues "monitoring and reporting on reconciliation legislation"; implementation of PL 119-21.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.